Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Nabil Adra; Liang Cheng; Roberto Pili

doi:10.1016/j.clgc.2016.12.019

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Nabil Adra, Liang Cheng, Roberto Pili

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Journal	Clinical Genitourinary Cancer
DOIs	https://doi.org/10.1016/j.clgc.2016.12.019
State	Accepted/In press - Dec 17 2016
Externally published	Yes

Keywords

Immunotherapy
Kidney cancer
Therapeutic
Unclassified renal cancer
Undifferentiated

ASJC Scopus subject areas

Oncology
Urology

Access to Document

10.1016/j.clgc.2016.12.019

Cite this

@article{7325f9d39e8f43b48dc324fda0b37754,

title = "Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab",

keywords = "Immunotherapy, Kidney cancer, Therapeutic, Unclassified renal cancer, Undifferentiated",

author = "Nabil Adra and Liang Cheng and Roberto Pili",

year = "2016",

month = dec,

day = "17",

doi = "10.1016/j.clgc.2016.12.019",

language = "English (US)",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier",

}

TY - JOUR

T1 - Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

AU - Adra, Nabil

AU - Cheng, Liang

AU - Pili, Roberto

PY - 2016/12/17

Y1 - 2016/12/17

KW - Immunotherapy

KW - Kidney cancer

KW - Therapeutic

KW - Unclassified renal cancer

KW - Undifferentiated

UR - http://www.scopus.com/inward/record.url?scp=85009480300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009480300&partnerID=8YFLogxK

U2 - 10.1016/j.clgc.2016.12.019

DO - 10.1016/j.clgc.2016.12.019

M3 - Article

AN - SCOPUS:85009480300

SN - 1558-7673

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

ER -

Unclassified Renal Cell Carcinoma With Significant Response to Nivolumab

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this